Skip to content

NTLA - Intellia Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchN

Intellia Therapeutics Inc

NTLA · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

N

NTLAIntellia Therapeutics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $28.25
52-wk low: $7.95
Prev close: $18.69
Mkt cap: $1.63B
Beta: 1.79
P/S: 27.3x

Smart money

8 funds hold a position and insiders have been net selling.

Real smart money

Funds holding this stock

8 holders

Combined position$1.0B

CW
Cathie Wood
Q2 2026 13F
$285.5M
position
DS
D.E. Shaw
Q2 2026 13F

Earnings

Reported Aug 6, 2026

Earnings landed in line with what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $1.6B

Valuation

P/S27.32
P/B2.33

Quality

Operating margin-1472.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: NTLA
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $1.63B
Beta: 1.79

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

2.3x

Profit margin

+0.0%

Op margin

-1472.0%

ROE

-55.4%

$109.0M

position

TS

Two Sigma

Q2 2026 13F

$88.6M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for NTLA

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.80+0.0%

-$0.80 expected

Next report

What the street expects next

-55.4%

ROA-30.1%

Growth

Beta1.79